UnitedHealth Group (UNH): Operating profit jumps 52% as medical costs ease and the outlook is raised, but sales dip 0.4%
UnitedHealth Group, the largest US health insurer and owner of the Optum health-services business, reported third-quarter revenue of $112.7 billion, down 0.4% from a year earlier. Earnings from operations rose 52% to $6.6 billion and adjusted earnings per share rose 61% to $4.69, helped by lower medical costs and a one-off reserve release. The company raised its 2026 profit outlook to at least $20.50 per share.
What happened
On Tuesday 13 October 2026, UnitedHealth Group published results for the third quarter, the three months to 30 September, in a filing with the US Securities and Exchange Commission. Total revenues were $112,694 million, against $113,161 million a year earlier. Earnings from operations, the profit from running the business before interest and tax, were $6,563 million, against $4,315 million. The company also raised its forecast for the full year: it now expects adjusted earnings per share of at least $20.50, up from a range of $19.50 to $20.00 given in July.
The improvement came mainly from the insurance side. UnitedHealthcare, which sells health plans to employers, individuals, Medicare and Medicaid members, earned $2,831 million from operations against $1,805 million. Optum Health, which runs clinics and doctor networks, earned $735 million against $41 million. Optum Rx, the pharmacy benefit business that manages prescription drug spending for employers and insurers, earned $1,718 million against $1,549 million. The company said the quarter included $610 million of favourable "prior-period reserve development", meaning it had set aside more money for past medical claims than it ended up needing and released the surplus.
The numbers, explained
Revenue fell $467 million, or 0.4% ($112,694M less $113,161M, divided by $113,161M). Premiums, the payments members and employers make for coverage, fell 2.1%, from $88,979M to $87,078M, while products (mainly pharmacy sales) rose from $13,296M to $14,293M and services from $9,754M to $10,246M. Behind the dip is a smaller customer base: UnitedHealthcare served 48.3 million people at 30 September 2026, against 50.1 million a year earlier, a fall of about 3.6%. Optum Health revenue fell 9.9%, from $25,422M to $22,910M, and Optum Rx's adjusted prescription count fell 5.1%, from 414 million to 393 million.
The key insurance measure is the medical care ratio: the share of premium income paid out in medical claims. It was 88.4%, against 89.9% a year earlier and 86.7% in the second quarter, so costs improved by 1.5 percentage points on the year but rose from the previous quarter. By our working, the $610 million reserve release is worth about 0.7 points of that ratio ($610M divided by $87,078M of premiums), so without it the ratio would have been about 89.1%. That is our estimate; the company does not quote it. The operating cost ratio, running costs as a share of revenue, fell from 13.5% to 12.8%.
Per-share figures: net earnings were $4,300 million against $2,543 million, up 69%. Earnings per share under US accounting rules (GAAP) were $4.56 against $2.59, up 76%. Adjusted earnings per share, which leave out items such as gains and losses on selling businesses, were $4.69 against $2.92, up 60.6% (a rise of $1.77). Investing.com reports analysts had expected $4.12 of adjusted earnings per share and $111.31 billion of revenue; those are estimates, not reported results, and on that basis the quarter was $0.57 per share ahead. Cash from operations was $5.1 billion in the quarter and $25,087 million over nine months, against $18,589 million, up 35%.
Why it matters
UnitedHealth earns money in two main ways. UnitedHealthcare collects premiums and pays members' medical bills, keeping the difference, so its profit depends on predicting claims correctly. Optum sells services to the wider health system, including clinics, data and pharmacy management. In its call, management said commercial medical cost growth is still above 11%, driven by out-of-network arbitration awards under the No Surprises Act, expensive specialty drugs and more intensive care. It said Medicare Advantage profit margins should end 2026 near the top of a 2% to 4% range, and that 2026 is the low point for its Medicaid business.
The details also show a trade-off. Membership fell, partly because Medicaid enrolment dropped by 85,000 on eligibility changes, and Optum Health shrank because it serves fewer patients under value-based contracts, where doctors are paid to keep patients healthy rather than per visit. The $610 million reserve release and a $76 million loss on selling subsidiaries are one-off items, so readers should not treat the quarter's profit as a clean run rate.
What to watch next
Several dated or confirmed events follow. Management said on the call that Medicare's annual enrolment period begins this week; it runs from 15 October to 7 December and will show how many people choose UnitedHealthcare plans for 2027. The company said it will give formal membership guidance later in the year and will meet investors before year-end to give a fuller 2027 outlook. It says the lower end of its 13% to 16% long-term earnings growth target is a reasonable starting point for 2027, which is its own target, not a forecast we endorse. We did not find a confirmed date for the fourth-quarter results, so check the company's investor relations site.
- Key terms in plain words
- Medical care ratio: the share of premium income paid out in medical claims.
- Reserve development: the change when past claims cost less or more than the money set aside for them.
- Adjusted earnings: profit after leaving out one-off items the company chooses to exclude.
- Medicare Advantage: private health plans that cover people over 65 in place of standard Medicare.
Sources
More on UnitedHealth Group (UNH) · Healthcare takes
For information only. Not financial advice. See our disclaimer and editorial standards. Spotted an error? Tell us.
